Kukje Pharma Revenue

In the year 2024, Kukje Pharma had annual revenue of 156.46B KRW with 15.58% growth. Kukje Pharma had revenue of 41.64B in the quarter ending December 31, 2024, with 17.96% growth.

Revenue

156.46B

Revenue Growth

+15.58%

P/S Ratio

0.61

Revenue / Employee

641.24M

Employees

244

Market Cap

95.91B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	156.46B	21.09B	15.58%
Dec 31, 2023	135.37B	8.79B	6.94%
Dec 31, 2022	126.58B	6.84B	5.71%
Dec 31, 2021	119.75B	-10.65B	-8.17%
Dec 31, 2020	130.39B	19.27B	17.34%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,547.32B
Celltrion	3,557.30B
ALTEOGEN	102.85B
Yuhan	2,067.79B
SK Biopharmaceuticals	547.60B
HLB Co., Ltd.	68.13B
LigaChem Biosciences	125.90B
PharmaResearch	350.12B

Revenue Rankings